Browsing by Author "Milovanović, Andjela (57213394852)"
Now showing 1 - 4 of 4
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Authors' response (November 28, 2017) to the letter to the editor concerning the paper "screening commercial drivers for obstructive sleep apnea: Validation of stop-bang questionnaire"(2018) ;Popević, Martin B. (35732042800) ;Milovanović, Andjela (57213394852) ;Nagorni-Obradović, Ljudmila (57189629141) ;Nešić, Dejan (26023585700) ;Milovanović, Jovica (6603250148)Milovanović, Aleksandar P.S. (22035600800)[No abstract available] - Some of the metrics are blocked by yourconsent settings
Publication Screening commercial drivers for obstructive sleep apnea: validation of stop-bang questionnaire(2017) ;Popević, Martin B. (35732042800) ;Milovanović, Andjela (57213394852) ;Nagorni-Obradović, Ljudmila (57189629141) ;Nešić, Dejan (26023585700) ;Milovanović, Jovica (6603250148)Milovanović, Aleksandar P.S. (22035600800)Objectives: The main aim has been to examine psychometric properties of STOP-Bang (snoring, tiredness, observed apnea, high blood pressure, body mass index (BMI), age, neck circumference, male gender) scoring model (Serbian translation), an obstructive sleep apnea (OSA) screening tool, in a sample of commercial drivers. Material and Methods: After formal translation, validation was performed on a sample of bus and truck drivers evaluating test-retest reliability, construct and criterion validity. Overnight polysomnography or cardiorespiratory polygraphy were used for OSA diagnosis purposes. Results: One hundred male participants, 24–62 years old, were included. STOP-Bang classified 69% as potential OSA patients. Polysomnography identified OSA in 57% of the sample. Test-retest reliability (Cohen’s κ = 0.89) was adequate. STOP-Bang score was significantly correlated to apnea-hypopnea index (AHI) and OSA severity. Sensitivity was 100% for AHI ≥ 15, highest specificity was 53.5% (AHI ≥ 5). Conclusions: STOP-Bang showed good measurement properties, supporting its further use in OSA screening of commercial drivers. - Some of the metrics are blocked by yourconsent settings
Publication Serum Concentration of Prostaglandin E2 as a Diagnostic Biomarker in Patients With Silicosis: A Case-Control Study(2023) ;Milovanović, Aleksandar P. S. (22035600800) ;Milovanović, Andjela (57213394852) ;Srebro, Dragana (55601466500) ;Pajic, Jelena (51764352100) ;Stanković, Sanja (7005216636)Petrović, Tatjana (58478203900)Objective Silicosis is a prevalent incurable pneumoconiosis caused by inhalation of silica dust. Study aimed to investigate inflammatory, hematological, and biochemical parameters as additional biomarkers for diagnosing or monitoring silicosis. Methods Research enrolled 14 workers with silicosis and 7 healthy controls (without exposure and silicosis). The serum level of prostaglandin E2, C-reactive protein, fibrinogen, biochemical, and hematological parameters were measured. The receiver operating characteristic curve was used to determine diagnostic sensitivity of each biomarker. Results Patients with silicosis have a significantly higher level of prostaglandin E2, erythrocyte, hemoglobin, and hematocrit than patients without silicosis. Prostaglandin E2, hemoglobin, and the erythrocyte count are significant in separating the silicosis cases from healthy controls. Conclusions Prostaglandin E2 might be an adjuvant peripheral diagnostic biomarker for silicosis, while hematological parameters (erythrocytes, hemoglobin, and hematocrit) might be prognostic biomarkers. © 2023 American College of Occupational and Environmental Medicine. - Some of the metrics are blocked by yourconsent settings
Publication The impact of socioeconomic factors on quality of life and functional impairment in patients treated for oropharyngeal carcinoma(2019) ;Milovanović, Jovica (6603250148) ;Andrejić, Dragoslava (13609301600) ;Jotić, Ana (35173257500) ;Djukić, Vojko (6701658274) ;Tošković, Oliver (28867554600) ;Savić-Vujović, Katarina (56362541300) ;Pavlović, Bojan (8212822900) ;Stojković, Goran (59498807300) ;Banko, Bojan (35809871900) ;Milovanović, Andjela (57213394852)Artiko, Vera (55887737000)Backround/Aim: Considering the distinct increase in the incidence of oropharyngeal cancer over oral cavity cancers and changing epidemiology with human papilloma virus (HPV) infection emerging as an important risk factor, there is a need to establish better treatment choices in specific groups of patients with oropharyngeal cancer. The aim of this study was to assess the quality of life (QOL) and functional performance and the impact of different demographical data, stage of disease, and treatment type on these parameters in patients with oropharyngeal cancer with successfully achieved locoregional control a year after the treatment. Methods: Study included 87 patients who underwent QOL and functional impairment assessment 12 to 14 months after finished oncological treatment with the following questionnaires: the European Organization for Research and Treatment of Cancer Quality-of Life-Questionnaire-C30 (EORTC QLQ-C30), European Organization for Research and Treatment of Cancer Quality of-Life Questionnaire-Head and Neck 35 (EORTC QLQ-H&N35) and The Karnofsky Performance Scale (KPS). Results: Specific groups of patients had significantly different post-treatment QOL scores. The factors associated with the worse QOL scores were female gender, not being in a partnership, level of education and HPV status. Conclusion: Clinicians should consider socioeconomic factors and HPV status in planning the recovery after treatment of patients with oropharyngeal carcinoma. Gender, education level and employment are the variables that form a certain risk profiles associated with the lower QOL. © 2019 Inst. Sci. inf., Univ. Defence in Belgrade. All rights reserved.